Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
21,509 Breast Cancer
clinical trials

Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
Wake Forest University at Mount Airy
mi
from
Mount Airy, NC
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Alphonsus Medical Center-Nampa
mi
from
Nampa, ID
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
Mount Sinai Union Square
mi
from
New York, NY
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Vincent Hospital Cancer Center at Oconto Falls
mi
from
Oconto Falls, WI
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
Baptist Memorial Hospital and Cancer Center-Oxford
mi
from
Oxford, MS
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
Mercy Health Perrysburg Cancer Center
mi
from
Perrysburg, OH
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
21st Century Oncology-Pontiac
mi
from
Pontiac, MI
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
Hope Cancer Center
mi
from
Pontiac, MI
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
Baptist Regional Cancer Network-Cancer Center of Southeast Texas
mi
from
Port Arthur, TX
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
McLaren-Port Huron
mi
from
Port Huron, MI
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
Rex Hematology Oncology Associates-Blue Ridge
mi
from
Raleigh, NC
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
Kaiser Permanente Downtown Commons
mi
from
Sacramento, CA
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
Lakeland Medical Center Saint Joseph
mi
from
Saint Joseph, MI
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
Maine Center for Cancer Medicine-Topsham
mi
from
Topsham, ME
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
Smilow Cancer Hospital-Torrington Care Center
mi
from
Torrington, CT
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
UM Saint Joseph Medical Center
mi
from
Towson, MD
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
ProHealth Waukesha Memorial Hospital
mi
from
Waukesha, WI
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
Fox Valley Hematology and Oncology SC - Waupaca
mi
from
Waupaca, WI
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
Valley Medical Group - Wayne Multispecialty Practice
mi
from
Wayne, NJ
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
WellSpan Health-York Hospital
mi
from
York, PA
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
Huron Gastroenterology PC
mi
from
Ypsilanti, MI
Click here to add this to my saved trials
Breast Cancer Clinical Trial
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Status: Enrolling, Phase
Updated: 12/31/1969
Texas Oncology - Allen
mi
from
Allen, TX
Click here to add this to my saved trials
Breast Cancer Clinical Trial
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Status: Enrolling, Phase
Updated: 12/31/1969
Providence & Providence Park Hospital
mi
from
Southfield, MI
Click here to add this to my saved trials
Metastatic Breast Cancer Clinical Trial
Palbociclib After CDK and Endocrine Therapy (PACE)
Status: Enrolling, Phase II
Updated: 12/31/1969
DF/BWCC in clinical affiliation with South Shore Hospital
mi
from
South Weymouth, MA
Click here to add this to my saved trials
Oncology Clinical Trial
Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With TNBC
Status: Enrolling, Phase II
Updated: 12/31/1969
Haukeland University Hospital
mi
from
Bergen,
Click here to add this to my saved trials
HER2-positive Breast Cancer Clinical Trial
Randomized Trial of Neo-adjuvant Chemotherapy With or Without Metformin for HER2 Positive Operable Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
The University of Kansas Cancer Center, South Clinic
mi
from
Kansas City, MO
Click here to add this to my saved trials
HER2-positive Breast Cancer Clinical Trial
Randomized Trial of Neo-adjuvant Chemotherapy With or Without Metformin for HER2 Positive Operable Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
The University of Kansas Cancer Center, Lee's Summit Clinic
mi
from
Lee's Summit, MO
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Evaluate The Accuracy Of Breast MRI Biopsy In Diagnosing A Complete Tumor Response For Some Women Following Neoadjuvant Chemotherapy For Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Memorial Sloan Kettering Westchester (Consent only)
mi
from
Harrison, NY
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Phase 1 / 2 Study of SAR439859 Single Agent and in Combination With Palbociclib in Postmenopausal Women With Estrogen Receptor Positive Advanced Breast Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib in Real World Practice
Status: Enrolling, Phase
Updated: 12/31/1969
St. Luke's Hospital- Allentown Campus
mi
from
Allentown, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib in Real World Practice
Status: Enrolling, Phase
Updated: 12/31/1969
CareMount Medical
mi
from
Brewster, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib in Real World Practice
Status: Enrolling, Phase
Updated: 12/31/1969
Maryland Oncology Hematology, P.A.
mi
from
Clinton, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib in Real World Practice
Status: Enrolling, Phase
Updated: 12/31/1969
Pontchartrain Cancer Center
mi
from
Hammond, LA
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib in Real World Practice
Status: Enrolling, Phase
Updated: 12/31/1969
University of Florida Health
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib in Real World Practice
Status: Enrolling, Phase
Updated: 12/31/1969
Breastlink Medical Group, Inc.
mi
from
Laguna Hills, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib in Real World Practice
Status: Enrolling, Phase
Updated: 12/31/1969
Ortenzio Cancer Center at Pinnacle Health
mi
from
Mechanicsburg, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib in Real World Practice
Status: Enrolling, Phase
Updated: 12/31/1969
Peninsula Cancer Institute/Riverside Cancer Infusion Center
mi
from
Newport News, VA
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib in Real World Practice
Status: Enrolling, Phase
Updated: 12/31/1969
Western Connecticut Health Network
mi
from
Norwalk, CT
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib in Real World Practice
Status: Enrolling, Phase
Updated: 12/31/1969
St. Helena Hospital
mi
from
Saint Helena, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib in Real World Practice
Status: Enrolling, Phase
Updated: 12/31/1969
St. Louis University Cancer Center
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib in Real World Practice
Status: Enrolling, Phase
Updated: 12/31/1969
University of Massachusetts Memorial Medical Center
mi
from
Worcester, MA
Click here to add this to my saved trials
Metastatic Breast Cancer Clinical Trial
Phase 2 Trial of Seribantumab Plus Fulvestrant in Postmenopausal Women With Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
James M. Stockman Cancer Institute
mi
from
Frederick, MD
Click here to add this to my saved trials
Metastatic Breast Cancer Clinical Trial
Phase 2 Trial of Seribantumab Plus Fulvestrant in Postmenopausal Women With Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
LKH - Universitätsklinikum Graz
mi
from
Graz,
Click here to add this to my saved trials
Metastatic Breast Cancer Clinical Trial
Phase 2 Trial of Seribantumab Plus Fulvestrant in Postmenopausal Women With Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Holy Cross Hospital Health Center
mi
from
Silver Spring, MD
Click here to add this to my saved trials
Oncology Clinical Trial
AZD5363 in Patients With Advanced Solid Tumors Harboring AKT Mutations
Status: Enrolling, Phase I
Updated: 12/31/1969
Memoral Sloan Kettering Monmouth
mi
from
Middletown, NJ
Click here to add this to my saved trials
Oncology Clinical Trial
Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy For Locally Advanced Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Memorial Sloan Kettering Westchester
mi
from
Harrison, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy For Locally Advanced Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Memorial Sloan Kettering @ Rockville
mi
from
Rockville Centre, NY
Click here to add this to my saved trials
Breast Cancer Clinical Trial
ASCENT-Study of Sacituzumab Govitecan in Refractory/Relapsed Triple-Negative Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Atlanta Cancer Center - Alpharetta
mi
from
Alpharetta, GA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
ASCENT-Study of Sacituzumab Govitecan in Refractory/Relapsed Triple-Negative Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Maryland Oncology Hematology PA
mi
from
Bethesda, MD
Click here to add this to my saved trials
Breast Cancer Clinical Trial
ASCENT-Study of Sacituzumab Govitecan in Refractory/Relapsed Triple-Negative Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Center for Cancer and Blood Disorders
mi
from
Burleson, TX
Click here to add this to my saved trials
Breast Cancer Clinical Trial
ASCENT-Study of Sacituzumab Govitecan in Refractory/Relapsed Triple-Negative Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Texas Oncology- Medical City Dallas Building D
mi
from
Dallas, TX
Click here to add this to my saved trials
Breast Cancer Clinical Trial
ASCENT-Study of Sacituzumab Govitecan in Refractory/Relapsed Triple-Negative Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Atlanta Cancer Care - Decatur
mi
from
Decatur, GA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
ASCENT-Study of Sacituzumab Govitecan in Refractory/Relapsed Triple-Negative Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Mercy Hospital - Unity Campus AHL
mi
from
Fridley, MN
Click here to add this to my saved trials
Breast Cancer Clinical Trial
ASCENT-Study of Sacituzumab Govitecan in Refractory/Relapsed Triple-Negative Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
UPMC Hillman Cancer Center Mountainview Arnold Palmer Pavilion
mi
from
Greensburg, PA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
ASCENT-Study of Sacituzumab Govitecan in Refractory/Relapsed Triple-Negative Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
GCS/Macon
mi
from
Macon, GA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
ASCENT-Study of Sacituzumab Govitecan in Refractory/Relapsed Triple-Negative Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Maryland Oncology Hematology P.A.
mi
from
Silver Spring, MD
Click here to add this to my saved trials
Breast Cancer Clinical Trial
ASCENT-Study of Sacituzumab Govitecan in Refractory/Relapsed Triple-Negative Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Florida Cancer Specialists
mi
from
Venice, FL
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of RO7198457 (Personalized Cancer Vaccine [PCV]) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Dana Farber Can Ins
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of RO7198457 (Personalized Cancer Vaccine [PCV]) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Columbia University Medical Center; Clinical Research Management Office
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
FATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Baylor Scott & White Research Institute
mi
from
Dallas, TX
Click here to add this to my saved trials
Breast Cancer Metastatic Clinical Trial
MCLA-128 With Trastuzumab/Chemotherapy in HER2+ and With Endocrine Therapy in ER+ and Low HER2 Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Institut Jules Bordet
mi
from
Brussel,
Click here to add this to my saved trials
Breast Cancer Metastatic Clinical Trial
MCLA-128 With Trastuzumab/Chemotherapy in HER2+ and With Endocrine Therapy in ER+ and Low HER2 Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Feinberg School of Medicine
mi
from
Chicago, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Care Coordination for Complex Cancer Survivors in an Integrated Safety Net System
Status: Enrolling
Updated: 10/25/2017
UT Southwestern Medical Center Department of Clinical Sciences
mi
from
Dallas, TX
Click here to add this to my saved trials
Recurrent or Metastatic Breast Cancer Clinical Trial
Oral Paclitaxel Efficacy Safety and PK in Recurrent and metAstatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Kansas Medical Center (KUMC)
mi
from
Kansas City, KS
Click here to add this to my saved trials
Breast Cancer Clinical Trial
A Study of Ipatasertib in Combination With Paclitaxel as a Treatment for Participants With PIK3CA/AKT1/PTEN-Altered, Locally Advanced or Metastatic, Triple-Negative Breast Cancer or Hormone Receptor-Positive, HER2-Negative Breast Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Brig Cancer Care
mi
from
Knoxville, TN
Click here to add this to my saved trials
Breast Cancer Clinical Trial
A Study of Ipatasertib in Combination With Paclitaxel as a Treatment for Participants With PIK3CA/AKT1/PTEN-Altered, Locally Advanced or Metastatic, Triple-Negative Breast Cancer or Hormone Receptor-Positive, HER2-Negative Breast Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
K. Permanente - San Jose
mi
from
San Jose, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Single Patient, Compassionate Use of MARGETUXIMAB for the Treatment of HER2+ Metastatic Breast Cancer
Status: Enrolling
Updated: 4/27/2017
Kaiser Foundation Research Institute
mi
from
Oakland, CA
Click here to add this to my saved trials
Oncology Clinical Trial
A Dose Escalation and Cohort Expansion Study of CD122-Biased Cytokine (NKTR-214) in Combination With Anti-PD-1 Antibody (Nivolumab) or in Combination With Nivolumab and Anti-CTLA4 Antibody (Ipilimumab) in Patients With Select Advanced or Metastatic Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Local Institution - Aurora
mi
from
Aurora, CO
Click here to add this to my saved trials
Oncology Clinical Trial
A Dose Escalation and Cohort Expansion Study of CD122-Biased Cytokine (NKTR-214) in Combination With Anti-PD-1 Antibody (Nivolumab) or in Combination With Nivolumab and Anti-CTLA4 Antibody (Ipilimumab) in Patients With Select Advanced or Metastatic Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Local Institution - Boston
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
A Dose Escalation and Cohort Expansion Study of CD122-Biased Cytokine (NKTR-214) in Combination With Anti-PD-1 Antibody (Nivolumab) or in Combination With Nivolumab and Anti-CTLA4 Antibody (Ipilimumab) in Patients With Select Advanced or Metastatic Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Local Institution - Indianapolis
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Oncology Clinical Trial
A Dose Escalation and Cohort Expansion Study of CD122-Biased Cytokine (NKTR-214) in Combination With Anti-PD-1 Antibody (Nivolumab) or in Combination With Nivolumab and Anti-CTLA4 Antibody (Ipilimumab) in Patients With Select Advanced or Metastatic Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Local Institution - Seattle
mi
from
Seattle, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab and Enobosarm in Treating Patients With Androgen Receptor Positive Metastatic Triple Negative Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
City of Hope Corona
mi
from
Corona, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab and Enobosarm in Treating Patients With Androgen Receptor Positive Metastatic Triple Negative Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
City of Hope Rancho Cucamonga
mi
from
Rancho Cucamonga, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Mirvetuximab Soravtansine and Gemcitabine Hydrochloride in Treating Patients With FRa-Positive Recurrent Ovarian, Primary Peritoneal, Fallopian Tube, Endometrial, or Triple Negative Breast Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
City of Hope Rancho Cucamonga
mi
from
Rancho Cucamonga, CA
Click here to add this to my saved trials
Oncology Clinical Trial
PF-06804103 Dose Escalation in HER2 Positive Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
(IRB#17-001086) Ronald Reagan UCLA Medical Center, Drug Information Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control
Status: Enrolling, Phase III
Updated: 12/31/1969
Memorial Sloan Kettering Westchester
mi
from
Harrison, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
EMMC Cancer Care
mi
from
Brewer, ME
Click here to add this to my saved trials
Oncology Clinical Trial
Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Metro-Minnesota NCI Community Oncology Research Program
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
UPMC (University of Pittsburgh Medical Center)
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC
Status: Enrolling, Phase III
Updated: 12/31/1969
Border Medical Oncology
mi
from
Albury,
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Chicago Medical Center-Duchossois Center for Advanced Medicine (DCAM)
mi
from
Chicago, IL
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC
Status: Enrolling, Phase III
Updated: 12/31/1969
Kadlec Regional Medical Center
mi
from
Kennewick, WA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC
Status: Enrolling, Phase III
Updated: 12/31/1969
Rocky Mountain Cancer Center
mi
from
Lakewood, CO
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC
Status: Enrolling, Phase III
Updated: 12/31/1969
CARTI Cancer Center
mi
from
Little Rock, AR
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC
Status: Enrolling, Phase III
Updated: 12/31/1969
Oncology Hematology West, P.C. dba Nebraska Cancer Specialists
mi
from
Papillion, NE
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC
Status: Enrolling, Phase III
Updated: 12/31/1969
Cancer Care-Torrance Memorial Physician Network
mi
from
Redondo Beach, CA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC
Status: Enrolling, Phase III
Updated: 12/31/1969
Mercy Hospital St. Louis - David C. Pratt Cancer Center
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC
Status: Enrolling, Phase III
Updated: 12/31/1969
San Luis Obispo Oncology & Hematology Health Center
mi
from
San Luis Obispo, CA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC
Status: Enrolling, Phase III
Updated: 12/31/1969
California Cancer Associates in Research and Excellence
mi
from
San Marcos, CA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC
Status: Enrolling, Phase III
Updated: 12/31/1969
HOPE Cancer Center of East Texas
mi
from
Tyler, TX
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Intraoperative Detection of Residual Cancer in Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Beaumont Troy
mi
from
Troy, MI
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Intraoperative Detection of Residual Cancer in Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Novant Health
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Capecitabine 7/7 Schedule With Neratinib in Patients With Metastatic HER2-Positive Breast Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Memorial Sloan Kettering Bergen
mi
from
Montvale, NJ
Click here to add this to my saved trials
Triple Negative Breast Neoplasms Clinical Trial
A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Inova Schar Cancer Institute
mi
from
Falls Church, VA
Click here to add this to my saved trials
Triple Negative Breast Neoplasms Clinical Trial
A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Hca Midwest Division
mi
from
Kansas City, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Washington, Fred Hutchinson Cancer Research Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Triple Negative Breast Cancer Clinical Trial
Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Harry and Jeanette Weinberg Cancer Center at Franklin Square
mi
from
Baltimore, MD
Click here to add this to my saved trials
Triple Negative Breast Cancer Clinical Trial
Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Aultman Medical Group Hematology and Oncology
mi
from
Canton, OH
Click here to add this to my saved trials
Triple Negative Breast Cancer Clinical Trial
Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Kaiser Permanente-Sunset
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Triple Negative Breast Cancer Clinical Trial
Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Illinois Cancer Care-Peru
mi
from
Peru, IL
Click here to add this to my saved trials